{"id":"nkm-injection","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"While the exact mechanism of action is not well-documented, it is believed to involve the modulation of a key cellular process to produce its desired outcome.","oneSentence":"NKM injection works by targeting a specific molecular pathway to achieve its therapeutic effect.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:23:12.189Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of acute ischemic stroke"}]},"trialDetails":[{"nctId":"NCT00846157","phase":"PHASE3","title":"Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients","status":"UNKNOWN","sponsor":"NKBio Co.Ltd.","startDate":"2007-09","conditions":"Diffuse Large B-cell Lymphoma","enrollment":276}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NKCell"],"phase":"phase_3","status":"active","brandName":"NKM injection","genericName":"NKM injection","companyName":"NKBio Co.Ltd.","companyId":"nkbio-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"NKM injection works by targeting a specific molecular pathway to achieve its therapeutic effect. Used for Treatment of acute ischemic stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}